echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Merck's 15-valent pneumococcal vaccine receives priority review to protect children and adolescents

    Merck's 15-valent pneumococcal vaccine receives priority review to protect children and adolescents

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Merck & Co.


    Pneumococcal disease is a disease caused by Streptococcus pneumoniae infection.


    Vaxneuvance is a 15-valent pneumococcal conjugate vaccine consisting of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F bound to the CRM197 carrier protein And 33F purified capsular polysaccharide composition


    This application is based on positive data obtained from phase 2 and phase 3 clinical trials of the vaccine in pediatric populations (including infants, children, and adolescents)


    These studies support the potential use of Vaxneuvance in a variety of clinical settings, including immunization for infants and young children, and special populations at increased risk of pneumococcal disease, such as children with HIV infection or sickle cell anemia


    Reference materials:

    [1] US FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck's Vaxneuvance™ (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.